Edwards Lifesciences to Host Earnings Conference Call on July 24, 2024

Rhea-AI Summary

Edwards Lifesciences (NYSE: EW), a global leader in patient-focused innovations for structural heart disease and critical care monitoring, has announced its plans to release Q2 2024 operating results. The company will host an earnings conference call on July 24, 2024, at 5:00 p.m. ET, following the market close.

Investors and analysts can participate in the conference call by dialing (877) 704-2848 or (201) 389-0893. The call will also be available live and archived on the 'Investor Relations' section of the Edwards website at ir.edwards.com. This event provides an opportunity for stakeholders to gain insights into the company's financial performance and future outlook.

Positive

• Edwards Lifesciences maintains its position as a global leader in patient-focused innovations for structural heart disease and critical care monitoring

Negative

• None.

IRVINE, Calif.--(BUSINESS WIRE)-- Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended June 30, 2024 after the market closes on Wednesday, July 24, 2024, and will host a conference call at 5:00 p.m. ET that day to discuss those results.

To participate in the conference call, dial (877) 704-2848 or (201) 389-0893. The call will also be available live and archived on the “Investor Relations” section of the Edwards website at ir.edwards.com.

About Edwards Lifesciences

Edwards Lifesciences is the global leader of patient-focused innovations for structural heart disease and critical care monitoring. We are driven by a passion for patients, dedicated to improving and enhancing lives through partnerships with clinicians and stakeholders across the global healthcare landscape. For more information, visit Edwards.com and follow us on Facebook, Instagram, LinkedIn, X and YouTube.

Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240717144899/en/

Media Contact: Amy Hytowitz, 949-250-4009

Investor Contact: Mark Wilterding, 949-250-6826

Source: Edwards Lifesciences Corporation

FAQ

When will Edwards Lifesciences (EW) release its Q2 2024 earnings?

Edwards Lifesciences (EW) will release its Q2 2024 earnings after the market closes on Wednesday, July 24, 2024.

What time is Edwards Lifesciences' (EW) Q2 2024 earnings conference call?

Edwards Lifesciences' (EW) Q2 2024 earnings conference call is scheduled for 5:00 p.m. ET on Wednesday, July 24, 2024.

How can investors participate in Edwards Lifesciences' (EW) Q2 2024 earnings call?

Investors can participate in Edwards Lifesciences' (EW) Q2 2024 earnings call by dialing (877) 704-2848 or (201) 389-0893. The call will also be available live and archived on the company's investor relations website.

What is Edwards Lifesciences' (EW) main business focus?

Edwards Lifesciences (EW) is the global leader in patient-focused innovations for structural heart disease and critical care monitoring.